The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-2-(4-((5-((1-(3-cyclopropylphenyl)ethyl)carbamoyl)-2,3-dimethyl-1H-indol-1-yl)methyl)phenyl)-2-methylpropanoic acid ID: ALA5284640
Max Phase: Preclinical
Molecular Formula: C33H36N2O3
Molecular Weight: 508.66
Associated Items:
Names and Identifiers Canonical SMILES: Cc1c(C)n(Cc2ccc(C(C)(C)C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C4CC4)c3)cc12
Standard InChI: InChI=1S/C33H36N2O3/c1-20-22(3)35(19-23-9-14-28(15-10-23)33(4,5)32(37)38)30-16-13-27(18-29(20)30)31(36)34-21(2)25-7-6-8-26(17-25)24-11-12-24/h6-10,13-18,21,24H,11-12,19H2,1-5H3,(H,34,36)(H,37,38)/t21-/m0/s1
Standard InChI Key: DVWSHWWLAFDNHD-NRFANRHFSA-N
Molfile:
RDKit 2D
38 42 0 0 0 0 0 0 0 0999 V2000
5.8145 -1.8668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1005 -1.4534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0995 -2.2784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9215 1.0266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9227 0.1975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2064 -0.2160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4884 0.1980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4913 1.0302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2082 1.4403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.6334 1.4414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.0468 2.1573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4601 1.4412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7769 1.4463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0594 1.0356 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.7800 2.2730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3450 1.4517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6275 1.0411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3481 2.2784 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.6275 0.2154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0891 -0.1950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0814 1.4588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7987 1.0520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8087 0.2214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6018 -0.0257 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.0819 0.6521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5855 1.3181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8314 2.1075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9086 0.6623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8668 -0.8088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6774 -0.9709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9370 -1.7550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7467 -1.9174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2934 -1.2960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0246 -0.5097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2154 -0.3511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6492 -0.8353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4601 -0.9964 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.3832 -0.0525 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
4 10 1 0
11 10 1 0
12 11 1 0
10 12 1 0
8 13 1 0
13 14 1 0
13 15 1 6
14 16 1 0
16 17 1 0
16 18 2 0
17 19 2 0
19 20 1 0
21 17 1 0
22 21 2 0
20 23 2 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 2 0
26 22 1 0
26 27 1 0
25 28 1 0
24 29 1 0
29 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 2 1 0
33 34 1 0
34 35 2 0
35 30 1 0
2 36 1 0
36 37 1 0
36 38 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 508.66Molecular Weight (Monoisotopic): 508.2726AlogP: 7.04#Rotatable Bonds: 8Polar Surface Area: 71.33Molecular Species: ACIDHBA: 3HBD: 2#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 4.37CX Basic pKa: ┄CX LogP: 7.47CX LogD: 4.56Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.27Np Likeness Score: -0.95
References 1. Xu XT, Shi LY, Ban YJ, Luo BL, Zhu GF, Guo B, Tang L, Sang ZP, Wang JT.. (2023) Design, synthesis and biological evaluation of cajanonic acid A analogues as potent PPAR γ antagonists., 80 [PMID:36414176 ] [10.1016/j.bmcl.2022.129081 ]